https://orcid.org/0000-0003-4393-2257
Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Stine Lassen, Thale Heintz, Tilde Pedersen, Christian Jentz, Naaja Nathanielsen, Parnuna Heilmann & Lisbeth Uhrskov Sørensen. (2023) Nationwide study on antipsychotic polypharmacy among forensic psychiatric patients. International Journal of Circumpolar Health 82:1.
Read now
Read now
Andrea de Bartolomeis, Mariateresa Ciccarelli, Licia Vellucci, Michele Fornaro, Felice Iasevoli & Annarita Barone. (2022) Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia. Expert Opinion on Pharmacotherapy 23:18, pages 2035-2052.
Read now
Read now
Mattia Marchi, Giacomo Galli, Federica Maria Magarini, Giorgio Mattei & Gian Maria Galeazzi. (2021) Sarcosine as an add-on treatment to antipsychotic medication for people with schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 483-493.
Read now
Read now
Articles from other publishers (7)
Lei Li, Jing Liu, Hongjun Ye & Kan Qin. (2023) Investigating the multitarget pharmacological mechanism of Wendan decoction in the treatment of schizophrenia. Journal of Herbal Medicine 41, pages 100707.
Crossref
Crossref
Aysha Jawed & Nadia Zaim. (2023) Inside the Bell Jar of Social Media: A Descriptive Study Assessing YouTube Coverage of Psychotropic Medication Adherence. International Journal of Environmental Research and Public Health 20:16, pages 6578.
Crossref
Crossref
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, Giuseppe Lamanna, Maria Cristina Lumuscio, Michele Saviano, Jean-Pierre Majoral, Serge Mignani, Andrea Duranti & Giovanni Lentini. (2023) Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective. Biomedicines 11:2, pages 469.
Crossref
Crossref
Jie Hu, Sara S McMillan, Theo Theodoros, Jack C Collins, Sarira El-Den, Claire L O’Reilly & Amanda J Wheeler. (2022) Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study. BMC Psychiatry 22:1.
Crossref
Crossref
H. H. Stassen, S. Bachmann, R. Bridler, K. Cattapan, D. Herzig, A. Schneeberger & E. Seifritz. (2021) Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 272:4, pages 603-619.
Crossref
Crossref
Michael Rentrop, Maximilian Huhn & Dirk Schwerthöffer. (2021) Clozapin in der Behandlung schizophrener Psychosen
Patientencharakteristika und antipsychotische Kombinationstherapien bei einem
Behandlungsjahrgang eines psychiatrischen
Versorgungskrankenhauses. Fortschritte der Neurologie · Psychiatrie 89:12, pages 622-629.
Crossref
Crossref
Stephan Hjorth. (2021) The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective. Frontiers in Psychiatry 12.
Crossref
Crossref